Sandoz

Sun, Camber join growing list of companies reporting Adderall supply problems
Fierce Pharma
Fri, 10/7/22 - 10:50 am
ADHD
Adderall
drug shortages
Sandoz
Sun Pharma
Novartis
A perfect storm: Europe's generic industry weighs cuts to output amid energy crisis, pricing pressures and more
Fierce Pharma
Wed, 09/28/22 - 11:38 am
generics
Europe
Teva Pharmaceutical
Sandoz
Unsealed documents detail Biogen's fight against Sandoz Tysabri biosimilar
Endpoints
Tue, 09/20/22 - 08:36 pm
Biogen
Novartis
Sandoz
biosimilars
Tysabri
MS
multiple sclerosis
Sandoz reports data from Phase I/III trial of denosumab for osteoporosis
Clinical Trials Arena
Tue, 09/20/22 - 10:07 am
Novartis
Sandoz
clinical trials
biosimilarts
denosumab
osteoporosis
Novartis cuts manufacturing jobs, closes North Carolina plant ahead of Sandoz spinoff
Fierce Pharma
Fri, 08/26/22 - 10:45 am
Novartis
drug manufacturing
Sandoz
generics
It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery
Fierce Pharma
Thu, 08/25/22 - 11:30 am
spinoffs
Novartis
Sandoz
generics
FDA reviewing higher dose Hyrimoz biosimilar
Biopharma Reporter
Fri, 07/22/22 - 11:14 am
FDA
Sandoz
biosimilars
Hyrimoz
Humira
AbbVie
Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: Bloomberg
Fierce Pharma
Fri, 07/1/22 - 09:49 am
Novartis
spinoffs
generics
M&A
Sandoz
private equity
More drug, fewer jabs: Novartis' Sandoz eyes EMA nod for high-concentration Humira copy
Fierce Pharma
Mon, 06/20/22 - 10:37 am
Novartis
Sandoz
AbbVie
Humira
Europe
biosimilars
autoimmune disease
EMA
Hyrimoz
Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide
Xtalks
Wed, 06/8/22 - 11:04 pm
Novartis
Sandoz
biosimilars
generics
Novartis' Sandoz founds new initiative to expand biosimilar use more globally
Endpoints
Tue, 05/31/22 - 11:51 pm
Novartis
Sandoz
biosimilars
Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Fierce Pharma
Fri, 05/13/22 - 10:46 am
Novartis
Sandoz
generics
Roche
Esbriet
idiopathic pulmonary fibrosis
Novartis' Sandoz, following Pfizer's lead, launches 2nd carcinogen-related drug recall this week
Fierce Pharma
Wed, 03/23/22 - 10:58 pm
Novartis
Sandoz
product recalls
generics
Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024
Fierce Pharma
Wed, 03/23/22 - 10:38 am
Novo Nordisk
Novartis
Sandoz
Victoza
generics
patents
diabetes
Sandoz bulks up ahead of possible sale with Coalesce buy
Pharmaforum
Mon, 03/14/22 - 10:21 am
Novartis
Sandoz
generics
M&A
Coalesce Product Development
Novartis sells pair of manufacturing plants as Sandoz strategic review rolls on
Fierce Pharma
Thu, 03/3/22 - 10:19 am
Novartis
drug manufacturing
Sandoz
No news anytime soon on Sandoz sale, says Novartis
Pharmaforum
Thu, 02/3/22 - 10:35 am
Novartis
Vas Narasimhan
Sandoz
generics
M&A
Novartis (NVS) Q4 Earnings & Sales Miss, Sandoz Review Ongoing
NASDAQ
Wed, 02/2/22 - 11:44 pm
Novartis
earnings
Sandoz
Novartis' Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone
Fierce Pharma
Tue, 02/1/22 - 11:26 pm
Novartis
Sandoz
M&A
Blackstone
Carlyle
Teva and Novartis’ Sandoz launch Narcan generics on same day, brand marketer Emergent remains in play
Endpoints
Wed, 01/5/22 - 10:47 pm
Teva Pharmaceutical
Novartis
Sandoz
generics
Narcan
Emergent BioSolutions

Pages